HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer

Epigenetic mechanisms play an important role in the development and persistence of cancer, and histone deacetylase (HDAC) inhibitors are promising anticancer drugs targeting epigenetic modes. Efficient anticancer drugs for the treatment of castration-resistant prostate cancer (CRPC) are sought, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Biersack, Bernhard, Nitzsche, Bianca, Höpfner, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992583/
https://www.ncbi.nlm.nih.gov/pubmed/35582529
http://dx.doi.org/10.20517/cdr.2021.105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992583/
https://www.ncbi.nlm.nih.gov/pubmed/35582529
http://dx.doi.org/10.20517/cdr.2021.105

Ejemplares similares